Mount Sinai Medical Center, internationally acclaimed for its excellence in research, patient care, education in multiple sclerosis and a range of medical specialties, was recruited by clinical sponsor BrainStorm Cell Therapeutics, Inc (BCLI) as a clinical trial site...
The Karolinska Institutet and the Academic Specialist Center (ASC), Stockholm, Sweden will conduct a clinical trial of temelimab in multiple sclerosis (MS) with commercial sponsor GeNeuro. Led by Dr. Fredrik Piehl, Professor of Neurology, Department of Clinical...
Dr. Rany Aburashed at Memorial Healthcare Https://www.memorial healthcare.org/ in Owosso, Michigan is conducting new research in a quest to find ways to stop the progression of Multiple Sclerosis. A local newscast reported on some recent evidence of success. Multiple...
The National Multiple Sclerosis Society (NMSS) awarded $14.6 million in grants supporting 43 new and multiyear research projects into multiple sclerosis (MS), part of a projected $36 million investment in disease research for 2019, the society announced on its...
The Western Canadian plains of Saskatchewan are vast and expansive, and, at times, it would appear life moves fairly slow there. Named after “the swiftly flowing river” Saskatchewan is a hotbed for Multiple Sclerosis cases. The University of Regina represents a nexus...
“Helper” T cells are white blood cells that launch an inflammatory attack on the brain and spinal cord when a person has multiple sclerosis, an autoimmune disorder. Boston Children’s Hospital pinpoints the specific subgroup of help T cells that cause MS, as well as...
